XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Schedule of Carrying Value and Fair Value of Assets and Liabilities
The following table shows assets and liabilities that are measured at fair value on a recurring basis and their carrying value (in millions):
June 30, 2022
Fair Value
Carrying ValueLevel 1Level 2Level 3
Cash and cash equivalents$416.1 $416.1 $— $— 
Marketable securities$148.6 $148.6 $— $— 
Deferred consideration$10.8 $— $10.8 $— 
Contingent consideration liabilities$55.6 $— $— $55.6 
December 31, 2021
Fair Value
Carrying ValueLevel 1Level 2Level 3
Cash and cash equivalents$716.8 $716.8 $— $— 
Marketable securities$50.0 $50.0 $— $— 
Deferred consideration$14.9 $— $14.9 $— 
Contingent consideration liabilities$75.7 $— $— $75.7 
Summary of Observable Inputs in Valuation of Deferred Consideration
The following observable input was used in the valuation of the deferred consideration as of June 30, 2022:
Fair Value as of June 30, 2022 (in millions)
Observable InputInput Value
Deferred consideration$10.8
Insmed share price as of June 30, 2022
$19.72
Summary of Significant Unobservable Inputs Used in the Valuation of the Contingent Consideration Payables
The following significant unobservable inputs were used in the valuation of the contingent consideration liabilities as of June 30, 2022 (in millions):

Contingent Consideration Liabilities
Fair Value as of June 30, 2022
Valuation TechniqueUnobservable InputsValues
Development and regulatory milestones$50.6Probability-adjustedProbabilities of success
14% - 95%
Priority review voucher milestone$5.0Probability-adjusted discounted cash flowProbability of success
13.5%
Discount rate
10.7%
The following table is a summary of the changes in the fair value of the Company's valuations for the deferred and contingent consideration liabilities for the six months ended June 30, 2022 (in thousands):
December 31, 2021AdditionsChange in Fair ValueAdjustmentsJune 30, 2022
Deferred consideration$14,931 — (4,172)— $10,759 
Contingent consideration$75,668 — (20,068)— $55,600 
Reconciliation of the Weighted Average Number of Shares Used to Compute Basic and Diluted Net Loss per Share
The following table sets forth the reconciliation of the weighted average number of common shares used to compute basic and diluted net loss per share for the three and six months ended June 30, 2022 and 2021:
 
 Three Months Ended June 30,Six Months Ended June 30,
 2022202120222021
 (in thousands, except per share amounts)
Numerator:    
Net loss$(95,645)$(117,321)$(190,266)$(208,962)
Denominator:    
Weighted average common shares used in calculation of basic net loss per share:119,602 109,580 119,267 106,328 
Effect of dilutive securities:    
Common stock options— — — — 
Restricted stock and RSUs— — — — 
PSUs— — — — 
Convertible debt securities— — — — 
Weighted average common shares outstanding used in calculation of diluted net loss per share119,602 109,580 119,267 106,328 
Net loss per share:    
Basic and diluted$(0.80)$(1.07)$(1.60)$(1.97)
Potentially Dilutive Securities Excluded from Computations of Diluted Weighted Average Common Shares Outstanding
The following potentially dilutive securities have been excluded from the computations of diluted weighted average common shares outstanding as of June 30, 2022 and 2021, respectively, as their effect would have been anti-dilutive (in thousands):
 
June 30,
 20222021
Common stock options17,806 14,449 
Unvested restricted stock and RSUs1,619 1,125 
PSUs670 — 
Convertible debt securities23,438 23,438 
Schedule of Percentage of Total Gross Product Revenue Represented by the Three Largest Customers The following table presents the percentage of gross product revenue represented by the Company's three largest customers as of the six months ended June 30, 2022 and 2021.
June 30,
20222021
Customer A36%25%
Customer B32%23%
Customer C19%—%
Revenue from External Customers by Geographic Areas
The following table presents a summary of the Company's product revenues, net, by geographic location for the three and six months ended June 30, 2022 and 2021 (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
US$47,190 $41,754 $87,972 $79,008 
Japan15,849 — 26,525 — 
Europe and rest of world2,182 3,612 3,831 6,572 
  Total product revenues, net$65,221 $45,366 $118,328 $85,580